Newsletter
Sign Up And Receive Our Latest Promotions!
Thank you! Your submission has been received!
.svg){kind=small}
RETINAI Discovery®
Enabling the right decisions in clinics, research & pharma
Data Management
Data harmonization, aggregation, collection and advanced data processing
Data Connectivity
Single, unified repository of datawhich is secure, cloud-based withreal-time data access from anywhere and at anytime
AI Enrichment
In-house built AI models to extract automatic insights on patient diseases and outcomes
RetinAI Discovery®
Privacy & Security
Certified (CE/FDA)
Interoperability
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Discovery® Products
DISCOVERY UNITY - FOR PHARMA & LIFE SCIENCES
RetinAI Discovery® UNITY is designed to improve the healthcare decision process in Ophthalmology. It is one platform for unification and structuring of data in a single ecosystem.
By unlocking the power of data, Discovery UNITY helps pharmaceutical and life sciences build unparalleled disease understanding to help guide and accelerate research and development for better patient care.
Learn MoreBy unlocking the power of data, Discovery UNITY helps pharmaceutical and life sciences build unparalleled disease understanding to help guide and accelerate research and development for better patient care.
DISCOVERY for CLINICAL STUDIES - FOR PHARMA & LIFE SCIENCES, CROs, RESEARCHERS
RetinAI Discovery® for Clinical Studies uses a decentralized approach for multi-modal image and data collection and management, empowering decision makers with innovative AI tools for endpoint analysis and supporting patient assessment and enrollment. The certified platform accelerates clinical studies by effectively managing data at scale from multiple vendors and data sources.
Learn More
DISCOVERY FOR CLINICS - FOR OPHTHALMOLOGISTS & OPTOMETRISTS
Bring Intelligence to your Clinical Workflows & Patient Management by leveraging Discovery® for Clinics, powered by CE-marked & research use only AI models to enhance patient treatments & deliver the right treatment, at the point of care.
Learn More
RETINAI DISEASE APPS - FOR CLINICIANS
Our Disease Evaluation Apps provide easy-to-read reports, generated in a few minutes during the patient visit. The Apps are designed to support assessment of some of the most common vision-threatening diseases in ophthalmology: AMD, DR, DME, CME and GA* (*in Research Use Only).
Generate actionable insights to expand knowledge about your patients and their disease, and share these insights with your patients in just a few minutes!
Learn MoreGenerate actionable insights to expand knowledge about your patients and their disease, and share these insights with your patients in just a few minutes!
*Disclaimer
RetinAI Discovery is a CE-marked medical device according to the Medical Devices Regulation (EU) 2017/745
and the AI models are CE-marked devices according to Medical Devices Directive 93/42/EEC
RetinAI Discovery® is a 510(k) FDA Cleared medical device in US.
RetinAI Discovery® and Retinai® are both trademarks of RetinAI Medical AG.
The AI modules for biomarkers, fluid and layer segmentation and quantification
in retinal pathologies are for research use only in the USA.
The Advanced Segmentation and GA modules are for research use only.
Please be advised these tools are not intended to be a substitute for medical advice, diagnosis or treatment.
We do not warrant any reliance on the accuracy, completeness or usefulness of any content.
